India's Cosmo First's strategic investments drive revenue in FY25

The EBITDA growth was driven by a 10 per cent rise in specialty sales, ₹25 crore in cost rationalisation, improved margins in biaxially oriented polypropylene (BOPP) and biaxially oriented polyethylene terephthalate (BOPET) films, and strong performance of the specialty chemical subsidiary.

The company invested ₹1,180 crore (~$137.96 million) over the past three years—including ₹502 crore in the last year—across multiple growth projects such as BOPP, cast polypropylene (CPP), and polyester lines, metallisers, coating lines, sunshield/paint protection films, Zigly, and rigid packaging. These are expected to significantly boost revenue and profitability over the next two to three years, Cosmo First said in a press release.

The CPP line with a capacity of 22,000 metric tonnes per annum began operations in March 2025, while sunshield films commenced in May 2025. Cosmo First completed pilot runs with over 50 distributors for both sunshield and paint protection films.

The new BOPP line with an annual capacity of 81,000 metric tonnes is slated to start operations in Q1 FY26. Meanwhile, the specialty chemical subsidiary posted EBITDA in the high teens with a topline of ₹180 crore in FY25.

In the fourth quarter (Q4) of FY25, the company’s net revenue rose to ₹746 crore (~$87.26 million), up from ₹641 crore in Q4 FY24. EBITDA stood at ₹85 crore with an EBITDA margin of 11 per cent, matching the margin from the same quarter last year.

PBT increased to ₹33 crore from ₹18 crore in Q4, while PAT nearly doubled to ₹27 crore from ₹15 crore. EPS for the quarter stood at ₹11, up from ₹6.

EBITDA could have been higher if not for a one-time, non-recurring cost of ₹4.3 crore incurred for shifting the thermal line from Korea to India—which is expected to deliver annual efficiencies of ₹10 crore—and a planned shutdown that led to a 10 per cent reduction in BOPET film volume, added the release.

ALCHEMPro News Desk (SG)